DB16248InvestigationalSmall molecule
Nanoparticle Epirubicin is under investigation in clinical trial NCT03168061 (Dose-escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma). It is a novel epirubicin... It is a novel epirubicin drug-conjugated polymeric micelle.
- Also known as
- Micellar nanoparticle-encapsulated epirubicin
- Code names
- K-912 · NC-6300
What you can answer from here — as of April 23, 2025
Which companies are running trials of Nanoparticle Epirubicin, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account